Related Experiment Video

Updated: Aug 9, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Oncolytic viral therapies

Eugene Lin1, John Nemunaitis

  • 1Mary Crowley Medical Research Center, Dallas, Texas, USA.

Cancer Gene Therapy
|August 3, 2004
PubMed

Insights

Oncolytic viruses, engineered to destroy cancer cells, show promise in clinical trials. While efficacy varies, some patients experience dramatic responses, highlighting their potential in cancer therapy.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Molecular research has improved understanding of cancer growth and metastasis.
  • Targeted cancer therapies based on molecular science show significant promise.
  • Oncolytic viruses are engineered to selectively replicate in and kill cancer cells.

Purpose of the Study:

  • To review clinical trial outcomes of oncolytic virus therapy for cancer.
  • To summarize the safety and efficacy of oncolytic viruses in clinical settings.

Main Methods:

  • Review of published clinical trial data on oncolytic viruses.
  • Analysis of safety profiles and patient responses in cancer treatment studies.

Main Results:

  • Oncolytic virus therapy has demonstrated confirmed safety in clinical trials.
  • Variable efficacy has been observed, with some dramatic patient responses noted.
  • Several oncolytic viruses are under active clinical investigation for cancer treatment.

Conclusions:

  • Oncolytic viruses represent a promising targeted approach in cancer treatment.
  • Further research and clinical trials are warranted to optimize oncolytic virus therapy.
  • The potential for significant patient responses underscores the value of this therapeutic strategy.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...